PRKAA2 HiBiT HEK293 Harbor™ Cell Line

热销产品

undefined
+
  • undefined

编号 :

LMH01024162409

产品编号: LMH01024162409

市场价

销售价格:  咨询

数量
-
+

库存剩余

联系我们订购

抗体定制服务咨询

隐藏域元素占位

  • 产品描述
  • 细胞复苏
  • 细胞传代
  • 细胞冻存
  • 验证数据
    • 商品名称: PRKAA2 HiBiT HEK293 Harbor™ Cell Line
    • 商品编号: LMH01024162409
    • 物种: human
    • 细胞形态: 多边形,上皮样细胞,贴壁
    • 规格: 冻存管1×10⁶/管或T25活细胞/瓶,贴壁细胞汇合度70%以上,悬浮细胞量1×10⁶/瓶
    • 完全培养基成分: MEM+10%FBS+1%P/S
    • 抗性基因: puro,2ug/ml
    • 培养环境: 37℃,5% CO2 的培养箱,1/3到 1/5传代
    • 传代比例: 1/3-1/5
    • 传代频次: 2-3天
    • 支原体检测: 阴性
    • 靶标蛋白及功能: Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. Involved in insulin receptor/INSR internalization (PubMed:25687571). AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1. In that process also activates WDR45 (PubMed:28561066). AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Plays an important role in the differential regulation of pro-autophagy (composed of PIK3C3, BECN1, PIK3R4 and UVRAG or ATG14) and non-autophagy (composed of PIK3C3, BECN1 and PIK3R4) complexes, in response to glucose starvation. Can inhibit the non-autophagy complex by phosphorylating PIK3C3 and can activate the pro-autophagy complex by phosphorylating BECN1 (By similarity).
    • 标签蛋白介绍: 粒曼生物定点Knock-in 体系能特异剪切人类第19 号染色体上的 AAVS1 位点,生成DNA 双链断裂(DSB),触发DNA 的自然修复机制,诱导位点与 AAVS1 供体 DNA 克隆之间发生同源重组(HR),将供体克隆上的 DNA 片段整合到基因组上的 safe harbor 位点。HiBiT小分子生物发光标签,分子大小1.3 kDa(11 个氨基酸残基)凭借 “尺寸极小、检测灵敏、无背景干扰” 的核心优势,成为蛋白表达追踪、互作分析、活细胞成像等研究的理想工具,尤其适合对标签干扰敏感的实验场景.
    • 细胞背景: [HEK-293]细胞是剪切过的人腺病毒5(Ad5)转染的人胚肾细胞形成的永生化细胞,293 [HEK-293]细胞包含并表达转染的Ad5基因。早期报道中指出,293 [HEK-293]细胞基因组中含有腺病毒5(Ad5)基因组的左侧端和右侧端的DNA,但是现在明确了只存在其左侧端的DNA。经过对Ad5的插入点的克隆测序发现,Ad5的1-4344位线性核苷酸整合入293 [HEK-293]细胞19号染色体(19q13.2)。293 [HEK-293]细胞为人类腺病毒载体扩增的宿主,可表达异常的玻连蛋白的细胞表面受体,由整合素β1亚单位和玻连蛋白受体α-v亚单位组成。
  • 01.  在 37℃水浴中预热完全培养基。
    02.  将冻存管在 37℃水浴中解冻 1-2 分钟。
    03.  将冻存管转移到生物安全柜中,并用 70% 乙醇擦拭表面。
    04.  拧开冻存管管盖,将细胞悬液轻轻转移到含有 9mL 完全培养基的无菌离心管中。
    05.  在室温下以 125g 离心 5-7 分钟,弃上清。
    06.  用 5mL 的完整培养基重悬细胞沉淀,将细胞悬液转移到 T25 培养瓶中。
    07.  将细胞转移到 37℃,5% CO2 的培养箱中培养。
    08.  参考传代比例:1/3 到 1/5 传代,2-3 天长满。

  • 01.  待培养瓶中细胞汇合度至 80%-90% 以上,可进行细胞传代。
    02.  将培养基、PBS、胰酶(0.25%Trypsin_EDTA Gibco 25200-056) 等从 4℃冰箱中拿出, 置于 37℃水浴中温度接近 37℃时取出并在瓶子表面喷洒 75% 酒精后置于生物安全柜中。

    03.  从培养箱中取出待传代的培养瓶,瓶身喷洒 75% 酒精后置于生物安全柜中。
    04.  为避免冲散细胞,沿培养瓶上壁 PBS 润洗细胞,清洗细胞后弃去,T25 加 2mL。
    05.  加入对应体积的胰酶(T75 加 1.5mL, T25 加 0.5mL)  ,并轻轻晃动瓶身使胰酶平铺满细胞 底部。可根据实际情况适当增加或减少用量。约 1-2min 后大部分细胞脱落时,加入对应体积的完全培养基终止消化,并用 5mL 移液管轻轻吹打至细胞全部脱落。
    06.  将细胞悬液转移至 15mL 离心管,悬液 300g 离心 5min,弃上清。
    07.  移取 5mL 完全培养基重悬细胞,按需求调整接种比例,并补充培养瓶中完全培养基,T75 加至 13-15mL,T25 加至 5mL,加 1% 双抗。
    08.  盖上瓶盖拧紧后轻轻晃动瓶身,使细胞混合均匀后置于 37℃,5% CO2 培养箱中。

  • 01.  准备冻存液,并提前预冷。
    02.  确保待冻存的细胞满足冻存要求,用显微镜检查以下状态:健康的外观及形态特征、所处生 长周期(对数晚期)、无污染或衰退迹象。
    03.  对细胞进行消化及离心处理(具体步骤参考传代培养流程)
    04.  按照每管 1mL 的量添加冻存液重悬细胞,吹打均匀后分装至冻存管。
    05.  将细胞放在程序降温盒中,在 -80℃冰箱中冷冻。
    06.  后续将细胞转移到液氮罐中,以便长期储存。

  • 粒曼检测HiBiT表达使用The Nano-Glo® HiBiT Lytic Detection System,该系统使用简单的加样-混合-读数检测操作流程,灵敏地定量细胞裂解物中的HiBiT标签蛋白。

产品类型: HiBiT报告细胞系

细胞系信息

物种

human

细胞形态

多边形,上皮样细胞,贴壁

规格

冻存管1×10⁶/管或T25活细胞/瓶,贴壁细胞汇合度70%以上,悬浮细胞量1×10⁶/瓶

完全培养基成分

MEM+10%FBS+1%P/S

抗性基因

puro,2ug/ml

培养环境

37℃,5% CO2 的培养箱,1/3到 1/5传代

传代比例

1/3-1/5

传代频次

2-3天

支原体检测

阴性

靶标蛋白及功能

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. Involved in insulin receptor/INSR internalization (PubMed:25687571). AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1. In that process also activates WDR45 (PubMed:28561066). AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1. Plays an important role in the differential regulation of pro-autophagy (composed of PIK3C3, BECN1, PIK3R4 and UVRAG or ATG14) and non-autophagy (composed of PIK3C3, BECN1 and PIK3R4) complexes, in response to glucose starvation. Can inhibit the non-autophagy complex by phosphorylating PIK3C3 and can activate the pro-autophagy complex by phosphorylating BECN1 (By similarity).

标签蛋白介绍

粒曼生物定点Knock-in 体系能特异剪切人类第19 号染色体上的 AAVS1 位点,生成DNA 双链断裂(DSB),触发DNA 的自然修复机制,诱导位点与 AAVS1 供体 DNA 克隆之间发生同源重组(HR),将供体克隆上的 DNA 片段整合到基因组上的 safe harbor 位点。HiBiT小分子生物发光标签,分子大小1.3 kDa(11 个氨基酸残基)凭借 “尺寸极小、检测灵敏、无背景干扰” 的核心优势,成为蛋白表达追踪、互作分析、活细胞成像等研究的理想工具,尤其适合对标签干扰敏感的实验场景.

细胞背景

[HEK-293]细胞是剪切过的人腺病毒5(Ad5)转染的人胚肾细胞形成的永生化细胞,293 [HEK-293]细胞包含并表达转染的Ad5基因。早期报道中指出,293 [HEK-293]细胞基因组中含有腺病毒5(Ad5)基因组的左侧端和右侧端的DNA,但是现在明确了只存在其左侧端的DNA。经过对Ad5的插入点的克隆测序发现,Ad5的1-4344位线性核苷酸整合入293 [HEK-293]细胞19号染色体(19q13.2)。293 [HEK-293]细胞为人类腺病毒载体扩增的宿主,可表达异常的玻连蛋白的细胞表面受体,由整合素β1亚单位和玻连蛋白受体α-v亚单位组成。

细胞培养说明

细胞复苏

01.  在 37℃水浴中预热完全培养基。
02.  将冻存管在 37℃水浴中解冻 1-2 分钟。
03.  将冻存管转移到生物安全柜中,并用 70% 乙醇擦拭表面。
04.  拧开冻存管管盖,将细胞悬液轻轻转移到含有 9mL 完全培养基的无菌离心管中。
05.  在室温下以 125g 离心 5-7 分钟,弃上清。
06.  用 5mL 的完整培养基重悬细胞沉淀,将细胞悬液转移到 T25 培养瓶中。
07.  将细胞转移到 37℃,5% CO2 的培养箱中培养。
08.  参考传代比例:1/3 到 1/5 传代,2-3 天长满。

细胞传代

01.  待培养瓶中细胞汇合度至 80%-90% 以上,可进行细胞传代。
02.  将培养基、PBS、胰酶(0.25%Trypsin_EDTA Gibco 25200-056) 等从 4℃冰箱中拿出, 置于 37℃水浴中温度接近 37℃时取出并在瓶子表面喷洒 75% 酒精后置于生物安全柜中。

03.  从培养箱中取出待传代的培养瓶,瓶身喷洒 75% 酒精后置于生物安全柜中。
04.  为避免冲散细胞,沿培养瓶上壁 PBS 润洗细胞,清洗细胞后弃去,T25 加 2mL。
05.  加入对应体积的胰酶(T75 加 1.5mL, T25 加 0.5mL)  ,并轻轻晃动瓶身使胰酶平铺满细胞 底部。可根据实际情况适当增加或减少用量。约 1-2min 后大部分细胞脱落时,加入对应体积的完全培养基终止消化,并用 5mL 移液管轻轻吹打至细胞全部脱落。
06.  将细胞悬液转移至 15mL 离心管,悬液 300g 离心 5min,弃上清。
07.  移取 5mL 完全培养基重悬细胞,按需求调整接种比例,并补充培养瓶中完全培养基,T75 加至 13-15mL,T25 加至 5mL,加 1% 双抗。
08.  盖上瓶盖拧紧后轻轻晃动瓶身,使细胞混合均匀后置于 37℃,5% CO2 培养箱中。

细胞冻存

01.  准备冻存液,并提前预冷。
02.  确保待冻存的细胞满足冻存要求,用显微镜检查以下状态:健康的外观及形态特征、所处生 长周期(对数晚期)、无污染或衰退迹象。
03.  对细胞进行消化及离心处理(具体步骤参考传代培养流程)
04.  按照每管 1mL 的量添加冻存液重悬细胞,吹打均匀后分装至冻存管。
05.  将细胞放在程序降温盒中,在 -80℃冰箱中冷冻。
06.  后续将细胞转移到液氮罐中,以便长期储存。

验证数据

粒曼检测HiBiT表达使用The Nano-Glo® HiBiT Lytic Detection System,该系统使用简单的加样-混合-读数检测操作流程,灵敏地定量细胞裂解物中的HiBiT标签蛋白。